default author photo

Sharon A. Glynn

University of Galway

Galway

Ireland

SCHOLARLY PAPERS

1

DOWNLOADS

24

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+ T Cell Spatial Orientation and Density

Number of pages: 23 Posted: 16 Aug 2022
National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, Government of the United States of America - National Cancer Institute, National Cancer Institute - Center for Cancer Research, National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, Molecular Histopathology Laboratories, Leidos Biomedical Research Inc., Molecular Histopathology Laboratories, Leidos Biomedical Research Inc., Government of the United States of America - Laboratory of Human Carcinogenesis, National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, University of Oxford - Nuffield Department of Surgical Sciences, Office of the Director, Division of Cancer Treatment and Diagnosis, Government of the United States of America - National Cancer Institute, Houston Methodist Cancer Center - Department of Systems Medicine and Bioengineering, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - National Cancer Institute, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, Houston Methodist Hospital - Houston Methodist Cancer Center, University of Galway, Government of the United States of America - Laboratory of Human Carcinogenesis and National Laboratory for Cancer Research
Downloads 24 (1,411,822)

Abstract:

Loading...

NOS2, COX2, TNBC, CD8+ T cells